ACTIVE PHARMA AS: årsregnskap 2024 vs 2023
Shrank 100% on revenue, weaker earnings
approved 2025-06-17; registry 2025-06-25; journal 2025 574071
Summary
What changed
Comparing Årsregnskap 2024 with 2023 for ACTIVE PHARMA AS. Revenue 412.3k NOK → 506 NOK (-99.9%). Net result +212.0k NOK → +12.7k NOK. Equity 34.4k NOK → 47.1k NOK.
On the constructive side: equity strengthened; cash rose. Pressures included: revenue fell; operating result weakened; net result weakened.
Also worth watching: book investments changed; headcount (årsverk) changed. All figures are taken from the published annual accounts for ACTIVE PHARMA AS.
At a glance
Scorecard
What improved
-
↑
Equity strengthened
Book equity 34.4k NOK → 47.1k NOK (equity ratio 33.2% → 11.4%). Calculated
-
↑
Cash rose
Bank deposits 10.5k NOK → 225.7k NOK (+2051.7% YoY). Calculated
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 412.3k NOK to 506 NOK (-99.9% YoY). Calculated
-
↓
Operating result weakened
Operating result +213.7k NOK → +12.4k NOK (op. margin 51.8% → 2454.9%). Calculated
-
↓
Net result weakened
Net result +212.0k NOK → +12.7k NOK (net margin 51.4% → 2511.5%). Calculated
-
↓
Payroll up without matching revenue
Salary cost 173.4k NOK → 452.6k NOK (42% → 89454% of revenue). Calculated
Things to notice
-
·
Book investments changed
Investment / intangible book value 55.6k NOK → 46.4k NOK. Reported fact
-
·
Headcount (årsverk) changed
Reported FTEs 0.5 → 0.3. Reported fact